Literature DB >> 14593007

The management of acute mania.

Paul E Keck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14593007      PMCID： PMC261645          DOI： 10.1136/bmj.327.7422.1002

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Limits of the applicability and generalizability of drug trials in mania.

Authors:  Rasmus W Licht
Journal:  Bipolar Disord       Date:  2002       Impact factor: 6.744

2.  12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode.

Authors:  P E Keck; S L McElroy; S M Strakowski; S A West; K W Sax; J M Hawkins; M L Bourne; P Haggard
Journal:  Am J Psychiatry       Date:  1998-05       Impact factor: 18.112

3.  A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar I disorder.

Authors:  D A Solomon; C E Ryan; G I Keitner; I W Miller; M T Shea; A Kazim; M B Keller
Journal:  J Clin Psychiatry       Date:  1997-03       Impact factor: 4.384

4.  Importance of psychiatric diagnosis in prediction of clinical drug effects.

Authors:  D F Klein
Journal:  Arch Gen Psychiatry       Date:  1967-01

Review 5.  Bipolar disorder.

Authors:  Bruno Müller-Oerlinghausen; Anne Berghöfer; Michael Bauer
Journal:  Lancet       Date:  2002-01-19       Impact factor: 79.321

Review 6.  The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania.

Authors:  Heinz Grunze; Siegfried Kasper; Guy Goodwin; Charles Bowden; David Baldwin; Rasmus W Licht; Eduard Vieta; Hans-Jürgen Möller
Journal:  World J Biol Psychiatry       Date:  2003-01       Impact factor: 4.132

Review 7.  A review of randomized, controlled clinical trials in acute mania.

Authors:  P E Keck; J Mendlwicz; J R Calabrese; J Fawcett; T Suppes; P A Vestergaard; C Carbonell
Journal:  J Affect Disord       Date:  2000-09       Impact factor: 4.839

Review 8.  Methodological issues in developing new acute treatments for patients with bipolar illness.

Authors:  A J Rush; R M Post; W A Nolen; P E Keck; T Suppes; L Altshuler; S L McElroy
Journal:  Biol Psychiatry       Date:  2000-09-15       Impact factor: 13.382

Review 9.  Atypical antipsychotics and mood stabilization in bipolar disorder.

Authors:  Paolo Brambilla; Francesco Barale; Jair C Soares
Journal:  Psychopharmacology (Berl)       Date:  2003-02-27       Impact factor: 4.530

Review 10.  Combination treatment in bipolar disorder: a review of controlled trials.

Authors:  Carlos A Zarate; Jorge A Quiroz
Journal:  Bipolar Disord       Date:  2003-06       Impact factor: 6.744
View more
  4 in total

1.  After out-of-home mental health treatment: atypical antipsychotic medication use and the probability of returning to treatment.

Authors:  John Robst; Mary Armstrong; Norin Dollard
Journal:  Community Ment Health J       Date:  2011-08-20

2.  A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania.

Authors:  Rodrigo Machado-Vieira; Jair C Soares; Diogo R Lara; David A Luckenbaugh; João V Busnello; Getulio Marca; Angelo Cunha; Diogo O Souza; Carlos A Zarate; Flavio Kapczinski
Journal:  J Clin Psychiatry       Date:  2008-08       Impact factor: 4.384

3.  A randomized, 4-week double-blind placebo control study on the efficacy of donepezil augmentation of lithium for treatment of acute mania.

Authors:  Jing Chen; Zheng Lu; Mingyuan Zhang; Jie Zhang; Xiaodong Ni; Xuefeng Jiang; Heding Xu; Anisha Heeramun-Aubeeluck; Qiaoyan Hu; Hua Jin; John M Davis
Journal:  Neuropsychiatr Dis Treat       Date:  2013-06-17       Impact factor: 2.570

4.  A bibliometric analysis of bipolar affective disorders using density-equalizing mapping and output benchmarking.

Authors:  B H Vogelzang; C Scutaru; S Mache; K Vitzthum; B Kusma; O Schulte-Herbrüggen; D A Groneberg; D Quarcoo
Journal:  Indian J Psychiatry       Date:  2012-10       Impact factor: 1.759
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.